Bio-Techne CorpNASDAQ:TECH
- LAST PRICE71.5250
- TODAY'S CHANGE (%)-0.1250 (-0.1745%)
- Bid / Lots71.4900/ 2
- Ask / Lots71.6000/ 4
- Open / Previous Close71.7800 / 71.6500
- Day Range
- 52 Week Range
- Volume257,165
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TECH |
|---|---|---|
| 09:32 ET | 15544 | 72.115 |
| 09:34 ET | 1744 | 72.08 |
| 09:36 ET | 1165 | 72.27 |
| 09:38 ET | 1779 | 72.61 |
| 09:39 ET | 2400 | 72.39 |
| 09:41 ET | 700 | 72.54 |
| 09:43 ET | 3446 | 72.53 |
| 09:45 ET | 3030 | 72.195 |
| 09:48 ET | 7277 | 72.405 |
| 09:50 ET | 2258 | 72.59 |
| 09:52 ET | 2596 | 72.69 |
| 09:54 ET | 4962 | 72.815 |
| 09:56 ET | 10199 | 72.94 |
| 09:57 ET | 4413 | 73.09 |
| 09:59 ET | 1500 | 73.08 |
| 10:01 ET | 5787 | 73.165 |
| 10:03 ET | 1383 | 72.91 |
| 10:06 ET | 3629 | 72.67 |
| 10:08 ET | 2029 | 72.46 |
| 10:10 ET | 4690 | 72.39 |
| 10:12 ET | 11062 | 72.38 |
| 10:14 ET | 1902 | 72.295 |
| 10:15 ET | 1500 | 72.295 |
| 10:17 ET | 5199 | 72.2 |
| 10:19 ET | 1933 | 72.24 |
| 10:21 ET | 3200 | 72.155 |
| 10:24 ET | 300 | 72.205 |
| 10:26 ET | 2929 | 72.21 |
| 10:28 ET | 700 | 72.18 |
| 10:30 ET | 600 | 72.2 |
| 10:32 ET | 2050 | 72.14 |
| 10:33 ET | 4083 | 71.9408 |
| 10:35 ET | 1401 | 71.93 |
| 10:37 ET | 5565 | 71.775 |
| 10:39 ET | 3000 | 71.825 |
| 10:42 ET | 1508 | 71.82 |
| 10:44 ET | 3900 | 71.82 |
| 10:46 ET | 2400 | 71.7325 |
| 10:48 ET | 600 | 71.71 |
| 10:50 ET | 2589 | 71.6 |
| 10:51 ET | 1700 | 71.63 |
| 10:53 ET | 1700 | 71.52 |
| 10:55 ET | 1024 | 71.615 |
| 10:57 ET | 1125 | 71.7202 |
| 11:00 ET | 1400 | 71.86 |
| 11:02 ET | 900 | 71.74 |
| 11:04 ET | 300 | 71.745 |
| 11:06 ET | 2563 | 71.875 |
| 11:08 ET | 2707 | 71.97 |
| 11:09 ET | 800 | 71.92 |
| 11:11 ET | 100 | 72 |
| 11:13 ET | 1200 | 71.97 |
| 11:15 ET | 2300 | 71.73 |
| 11:18 ET | 393 | 71.7001 |
| 11:20 ET | 500 | 71.795 |
| 11:22 ET | 1374 | 71.72 |
| 11:24 ET | 840 | 71.69 |
| 11:26 ET | 1000 | 71.73 |
| 11:27 ET | 1500 | 71.7 |
| 11:29 ET | 800 | 71.64 |
| 11:31 ET | 100 | 71.64 |
| 11:33 ET | 700 | 71.65 |
| 11:36 ET | 700 | 71.7 |
| 11:38 ET | 1400 | 71.63 |
| 11:40 ET | 1672 | 71.67 |
| 11:42 ET | 897 | 71.66 |
| 11:44 ET | 100 | 71.625 |
| 11:45 ET | 1003 | 71.64 |
| 11:47 ET | 1100 | 71.585 |
| 11:49 ET | 591 | 71.54 |
| 11:51 ET | 718 | 71.56 |
| 11:54 ET | 961 | 71.525 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bio-Techne Corp | 11.3B | 56.9x | +23.61% |
Sarepta Therapeutics Inc | 14.9B | 1,990.4x | --- |
Insmed Inc | 10.9B | -12.6x | --- |
Medpace Holdings Inc | 12.8B | 41.8x | +35.10% |
Ionis Pharmaceuticals Inc | 7.0B | -17.8x | --- |
Halozyme Therapeutics Inc | 6.7B | 21.6x | --- |
Company Information
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.
Contact Information
- Headquarters
- 614 MCKINLEY PL N EMINNEAPOLIS, MN, United States 55413
- Phone
- 612-379-8854
- Fax
- 612-656-4400
Executives
- Independent Chairman of the Board
- Robert Baumgartner
- Chief Executive Officer, Chief Operating Officer, Director
- Kim Kelderman
- Chief Financial Officer, Executive Vice President - Finance
- James Hippel
- President - Protein Sciences Segment
- William Geist
- President - Diagnostics and Genomics Segment
- Matthew Mcmanus
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.3B |
|---|---|
Revenue (TTM) | $1.2B |
Shares Outstanding | 157.6M |
Dividend Yield | 0.45% |
Annual Dividend Rate | 0.3200 USD |
Ex-Dividend Date | 05-10-24 |
Pay Date | 05-24-24 |
Beta | 1.28 |
EPS | $1.26 |
Book Value | $12.47 |
P/E Ratio | 56.9x |
Price/Sales (TTM) | 9.8 |
Price/Cash Flow (TTM) | 36.0x |
Operating Margin | 22.13% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
